·|¡@¡@°T Á`´Á¼Æ¡G²Ä892´Á 2017¦~²Ä036´Á(106.09.04~106.09.08)~CAPA·|°T¤U¸ü~ ¬d Åç µn °O ¬Û Ãö °T ®§ ƒÜ ¥» ¶g °T ®§ 1. ªÀ¹Îªk¤H¥xÆWÃĪ««~½è¨ó·|q©ó106¦~9¤ë5¤é(¤G)¤U¤È2®É¡A°²¹ÃĸpÃÄùÛ¤j¼ÓB201·|ij«Ç¥l¶}¡uì®ÆÃÄ«~½èºÞ²z¨î«×ºë¶i¤§¬ã¨s»P±À°Ê-¤½¨ó·|·¾³q¨ó°Ó·|ij¡v¡A¥»¤½·|¥Ñ¼ï¨q¶³±`°È²z¨Æ¡B¾Gµq¤¤¥D¥ô©eû¤Î·¨°·§»¥D¥ô©eû¥Nªí¥X®u¡C ƒÜ ªñ ´Á °T ®§ 1. ¸gÀÙ³¡´¼¼z°]²£§½q©ó106¦~9¤ë19¤é(¤G)¤U¤È2®É¡A°²´¼¼z°]²£§½18¼Ó¤j§°ó¥l¶}¡u±M§Q¼f¬d°ò·Ç²Ä¤G½g²Ä¤Q¤@³¹±M§QÅv´Á¶¡©µªø¼f¬d°ò·Ç×q¯ó®×º[±M§Qªk©µªø¨î«××¥¿±ø¤å¤Î±M§QÅv´Á¶¡©µªø®Ö©w¿ìªk×¥¿¯ó®×¡v¤½Å¥·|(¶}·|³qª¾¡B·|ij¸ê®Æ1¡B·|ij¸ê®Æ2¡B·|ij¸ê®Æ3¡B·|ij¸ê®Æ4¡B·|ij¸ê®Æ5)¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C 2. ¤¤µØ¥Á°ê¶}µo©Ê»sÃĬã¨s¨ó·|q©ó106¦~9¤ë21¤é(¥|)08:30-17:00¡A°²°²°]¹Îªk¤H±iºaµo°ê»Ú·|ij¤¤¤ß11¼Ó1101·|ijÆUÁ|¿ì¡u³Ð·sÃÄ«~¥[³t¼f¬d¬yµ{°ê»Ú¬ã°Q·|¡v¡AÅwªï·|û¿ãÅD³ø¦W°Ñ¥[¡C ì ®Æ ÃÄ µo ®i ¬Û Ãö °T ®§ ƒÜ ¥» ¶g °T ®§ 1. ªÀ¹Îªk¤H¥xÆWÃĪ««~½è¨ó·|q©ó106¦~9¤ë5¤é(¤G)¤U¤È2®É¡A°²¹ÃĸpÃÄùÛ¤j¼ÓB201·|ij«Ç¥l¶}¡uì®ÆÃÄ«~½èºÞ²z¨î«×ºë¶i¤§¬ã¨s»P±À°Ê-¤½¨ó·|·¾³q¨ó°Ó·|ij¡v¡A¥»¤½·|ì®ÆÃĵo®i©eû·|¥Ñ·¨°·§»¥D¥ô©eû¥Nªí¥X®u¡C ·| °È µo ®i ¬Û Ãö °T ®§ ƒÜ ¥» ¶g °T ®§ 1. CAPA¡®TPADA ¨â·|·|°Èµo®i©eû·|Áp®u·|ij©ó106¦~9¤ë5¤é(¤G)¤¤¤È12:00-14:00¡A°²¨â·|¦X¸p¿ì¤½·|ij«Ç¥l¶}¡C ƒÜ ªñ ´Á °T ®§ 1. ¤º¬F³¡³qª¾¥»¤½·|Àòµû¬°105¦~«×¤u°Ó¦Û¥Ñ¾·~¹ÎÅéÁZ®ÄµûŲ¤§¥Òµ¥¹ÎÅé¡A¨Ã±N©ó106¦~9¤ë15¤é(¤)¤U¤È13:30°²°]¹Îªk¤H±iºaµo°ê»Ú·|ij¤¤¤ß11¼Ó1101·|ijÆUÁ|¦æ¡u105¦~«×ÁZÀu¤u°Ó¦Û¥Ñ¾·~¹ÎÅé¹{¼ú¨å§¡v¡A¥»¤½·|¥Ñ¯Î·½¤ô²z¨Æªø¥X®u¥Nªí¨ü¼ú¡A²±Ä_¹Å±`°È²z¨Æ¤Î³¯§Ó§»±`°È²z¨Æ¤@¦P¥X®uÆ[§¡C °T ®§ Âà ª¾ ¡¯¤½·|¦¬¤å ½Ã¥ÍºÖ§Q³¡ µo¤å¤é´Á/¤å¸¹¡G106.9.4/½Ã±Â¹¦r²Ä1061302465¸¹¨ç ¤½·|¦¬¤å106646¸¹(9¤ë) ¥D¦®¡G¡u¤¤µØ¥Á°ê¿é¤J³W©wF01¡BF02³f«~¤ÀÃþªí¡v¡A·~¸g¥»³¡©ó¤¤µØ¥Á°ê106¦~9¤ë4¤é¥H½Ã±Â¹¦r²Ä1061302460¸¹¤½§i×¥¿¡A¨Ã¦Û¤¤µØ¥Á°ê106¦~9¤ë8¥Í®Ä¡A½Ð¬d·Ó¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó
½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p µo¤å¤é´Á/¤å¸¹¡G106.9.5/ FDAÃĦr²Ä1061408386¸¹ ¨ç ¤½·|¦¬¤å106652¸¹(9¤ë) ¥D¦®¡G¦³Ãö¥xÆW¨ó©MÃæ»ÃÄQÅïªÑ¥÷¦³¤½¥q¥D°Ê¦^¦¬ÃÄ«~¡u"¨ó©M" ±Æ¦hÀùª`®g¾¯¢°¢¯¤½µ· MITOMYCIN-C KYOWA 10MG (½Ã¸pÃÄ¿é¦r²Ä021026¸¹)¡v(§å¸¹101ADA01¡B103ADB01¡B113AEA01¡B114AEB01¡B116AEE01¡B117AEE01¤Î120AEF01)¤@®×¡A½Ð¨Ì»¡©ú¬q¿ì²z¡A½Ð¬d·Ó¡C ¡°¤½¨ç¤U¸ü µo¤å¤é´Á/¤å¸¹¡G106.9.7/ FDAÃĦr²Ä1061408050¸¹ ¨ç ¤½·|¦¬¤å106657¸¹(9¤ë) ¥D¦®¡G¹Ãĸp«¥Ó¼t°ÓÀ³§Y®É§ó·s¡u¥xÆWÃÄ«~Á{§É¸ÕÅç¸ê°Tºô¡v©Ò¤½¶}¤§¤º®e¡A¸Ô¦p»¡©ú¬q¡A¨ÃÂા©ÒÄÝ·|û¡A½Ð¬d·Ó¡C ¡°¤½¨ç¤U¸ü ½Ã¥ÍºÖ§Q³¡¤¤¥¡°·±d«OÀI¸p µo¤å¤é´Á/¤å¸¹¡G106.9.1/°·«O¼f¦r²Ä1060035962¸¹ ¤½§i ¤½·|¦¬¤å1066648¸¹(9¤ë) ¥D¦®¡G¤½§i×¥¿§ttestosterone 5-alpha reductase inhibitor»s¾¯¤§ÃÄ«~µ¹¥I³W©w¡C ¡°¤½¨ç¤U¸ü¡Bªþ¥ó µo¤å¤é´Á/¤å¸¹¡G106.9.6/°·«O¼f¦r²Ä1060061184¸¹ ¤½§i ¤½·|¦¬¤å1066655¸¹(9¤ë) ¥D¦®¡G¤½§i¼È¤©¤ä¥I§tmorphine ¦¨¤ÀÃÄ«~Morfina Labesfal(sem conservantes) 20mg/mL, Solution for injection¦@1«~¶µ¡C |